More is known, and accepted as a matter of daily life, about how to sell a woman's sexuality than basic knowledge of what factors define its capacities to develop and change. Not surprisingly, women's sexuality is still seeking a legitimate place in scientific discourse, in spite of the fact that the sexual and reproductive issues women face worldwide include serious consequences to the physical and emotional health and welfare of women and their families. The present talk will selectively address these themes with data on sexual response, partner choice and sexuality in an aggressive world.
Conflict of Interest: Pfizer, Bayer HealthCare, and Zestra Laboratories
Financial Support/Funding: zer, UW Reproductive and Sexual Medicine Clinic The Kinsey Institute for Research in Sex, Gender and Reproduction NIH
Recorded at 19th WAS World Congress for Sexual Health - Sexual Health & Rights: A Global Challenge Göteborg (Sweden) - June 21 – 25, 2009